EBS SG&A Expenses

Emergent Biosolutions Inc · SG&A Expenses

EBS logo

EBS SG&A Expenses

Latest reported$181.10M
EBS SG&A Expenses ($340.30M → $181.10M)
High-resolution chart · PNG

EBS sg&a expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Emergent Biosolutions Inc SG&A Expenses — Annual fiscal periods (USD)
Period endingSG&A Expenses (USD)
186,600,000
298,700,000
356,700,000
339,500,000
348,700,000
304,100,000
273,500,000
202,500,000
142,900,000
143,100,000
121,145,000
108,594,000
84,583,000
76,018,000
74,282,000
76,205,000
73,786,000
55,076,000
55,555,000
44,601,000
42,793,000
30,323,000
0
13,397,000
340,300,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.